Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Dr. Martins said it would start paying a dividend in the current fiscal year after reporting a fall in annual profit as revenue was held back by weaker retail performance owing to the pandemic impact.
For the year ended 31 March 2021, pre-tax profit fell to £70.9 million from £101.0 million and revenue grew 15% to £773 million.
Revenue in both EMEA and Americas was up 17%, and 7% in APAC.
'In APAC we saw slower growth in Japan, our largest country in the region, due to the higher physical retail mix which was significantly impacted by Covid-19,' the company said.
The company left its guidance unchanged, and said it expected to begin paying a dividend in FY22.
'In FY22 we expect high teens revenue growth year on year, as we lap the Covid-19 impact experienced in FY21, the company said.
'From FY23 and over the medium-term we anticipate mid-teens revenue growth. We are targeting ecommerce to grow to 40% mix, with total DTC, including retail, of 60% mix,' it added.